An increase in ENO1 expression has been reported in human diseases (i.e., systemic sclerosis, type II diabetes mellitus, lupus, Alzheimer disease) and many cancers, as well as being involved in cell growth and hypoxia tolerance [27,28,29,30,31,32,33,34]. This evidence concerns the gene ENO1 and cancer.